Log In
BCIQ
Print this Print this
 

Acelarin (MTL-007, NUC-1031)

  Manage Alerts
Collapse Summary General Information
Company Morvus Technology Ltd.
DescriptionModified version of gemcitabine using Morvus' ProTide technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today